We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Software Developed for Bone and Soft Tissue Imaging

By MedImaging staff writers
Posted on 19 Mar 2008
New technology called the Degenerative Knee Indicator (DKI) will soon provide surgeons, radiologists, physiotherapists, and physicians with more image detail, at less cost, than conventional knee imaging technologies. More...
The DKI image provides the soft tissue detail achieved with magnetic resonance imaging (MRI) combined with the bone detail of an X-ray.

Biofusion plc (Cardiff, Wales, UK), a university intellectual property (IP) commercialization company, recently launched a new portfolio company, Demasq Limited, which is developing a range of innovative bone and soft tissue imaging products based on its advanced medical imaging technology.

Demasq is a new spinout company from Biofusion's partnership with Cardiff University (Cardiff, Wales, UK), and is the result of work carried out by Prof. Hechmi Toumi, a specialist at the muscle-bone-tendon unit of Cardiff University's School of Biosciences. Prof. Toumi has been advised in his work by Prof. John Fairclough, consultant orthopedic surgeon at University Hospital Wales (Cardiff, UK), and a leading knee specialist.

Demasq's first product, the DKI, will be launched in the United Kingdom and the United States in 2009. Similarly, Demasq is generating a pipeline of additional products for a range of imaging applications.

Knee pain is the most common musculoskeletal complaint for which patients seek medical advice, with nearly 20 million people visiting their physician with knee problems every year in the United States alone. Commenting on the launch and investment, David Baynes, chief executive officer of Biofusion, said, "We are very excited by the cutting edge advanced medical imaging technology that Demasq has developed. Its first product, which targets the multimillion-pound knee pain-diagnosis market, has the potential to revolutionize the diagnosis of knee problems for patients. We are particularly excited by the speed with which we believe we can launch the first product into the US and UK private sector markets.”

Commenting on the technology, Prof. Toumi, said, "This is an exciting venture, which promises to alter our perception of the conventional use of X-rays. The soft tissues, which have been invisible in the past are exactly the ones where most disease processes occur. The Degenerative Knee Indicator allows clinicians to determine the health or otherwise of these soft tissues.”

Also commenting on the technology, Prof. John Fairclough, from the University Hospital Wales, said, "The Demasq imaging technique offers to the medical world a revolutionary method of viewing conventional X-rays, which will be of great potential benefit to both the medical practitioners and the providers of healthcare. This exciting invention will potentially offer that rare combination of providing new information to clinicians to help patients while potentially reducing the cost to the health service.”


Related Links:
Biofusion
Cardiff University

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.